Jennifer Y Wo MD

Associate Professor in Radiation Oncology, Massachusetts General Hospital

Massachusetts General Hospital55 Fruit StreetBoston, MA 02114
Phone+1 617-726-6050
Fax+1 617-726-3603

Dr. Wo is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wo's full profile Already have an account?

Education & Training

Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2006 - 2010
Mount Auburn HospitalInternship, Internal Medicine, 2005 - 2006
Columbia University Vagelos College of Physicians and SurgeonsClass of 2005

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

ME State Medical License Active through 2027
NH State Medical License 2021 - 2027
MA State Medical License 2007 - 2026
RI State Medical License 2021 - 2024
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2015, 2017
CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2012, 2014-2015, 2017
CMS Meaningful Use Stage 1 Certification Partners Longitudinal Medical Record, Partners Healthcare System, 2012, 2014-2015, 2017

Clinical Trials

Concurrent Chemoradiation + 5-FU + Mitomycin-C in Anal Carcinoma
COMPLETED
EARLY_PHASE1

Publications & Presentations

PubMed

Transitioning from neoadjuvant chemoradiation to perioperative chemotherapy for esophageal adenocarcinoma: Impact on margins and pathologic outcomes.
Paolo de Angelis, Seif Elmankabadi, Samuel J Klempner, Matthew R Strickland, Jeffrey W Clark
JTCVS Open. 2026-08-01
Data and Dogma in Hepatocellular Carcinoma.
James S Good, Lauren E Henke, Nina N Sanford, Jennifer Y Wo, Michael D Chuong
International Journal of Radiation Oncology, Biology, Physics. 2026-08-01
Neoadjuvant Stereotactic Body Radiotherapy plus Immune Therapy Favorably Remodels the Hepatocellular Carcinoma Tumor Microenvironment.
Zoe Cosner, Zhoubo Guo, Cole Nawrocki, Bidish Patel, Hannah J Roberts
Clinical Cancer Research. 2026-07-17

Journal Articles

Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer
Harvey J Mamon, Paul L Nguyen, Theodore S Hong, Aparna Parikh, Jennifer Y Wo, Rinaa S Punglia, Ryan D Nipp, Annals of Surgical Oncology

Lectures

A pilot study of neoadjuvant FOLFIRINOX followed by chemoradiation for gastric and gastroesophageal cancer: Preliminary results.
ASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019

Press Mentions

Radiation Oncology Leaders Name 2025 Fellows of the American Society for Radiation OncologySeptember 10th, 2025
Practice Change: Transform Cancer Care Through Quality Improvement and Evidence-Based PracticeOctober 5th, 2021
Trial: Gains Seen on Inoperable Pancreatic CancerMay 30th, 2019